• news.cision.com/
  • Sanofi-Aventis Norge AS/
  • Taxotere®-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy In Early Stage Breast Cancer
Norsk

Taxotere®-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy In Early Stage Breast Cancer

Report this content


Taxotere®-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy In Early Stage Breast Cancer


------------------------------------------------------------
Informasjonen er sendt gjennom Cision http://newsroom.cision.com
Nedenstående filer kan lastes ned:
http://wpy.waymaker.net/client/waymaker1/WOLReleaseFile.aspx?id=634119&fn=wkr0029.pdf

Dokumenter og linker